Sinopharm Group (01099.HK) Announces First Three Quarters Results: Net Profit Attributable to Parent 5.314 Billion Yuan, Up 0.13% Year-on-Year

Zhitong Finance APP News, Sinopharm Group (01099.HK) announced its results for the nine months ended September 30, 2026. During the period, the Group recorded operating revenue of RMB 427.613 billion, a year-on-year decrease of 0.9%; net profit attributable to owners of the parent company was RMB 5.314 billion, a year-on-year increase of 0.13%; basic earnings per share were RMB 1.7.